Komori
M&A and Subsidiary Changes4360MANAC Chemical Partners Co.,LtdMaterials and Chemicals

Notice Regarding Change in Consolidated Subsidiary (Share Transfer)

The group will transfer all 270 shares of 八幸通商株式会社 held by マナック株式会社, representing 90.0% of the shares, to 渡辺化学工業株式会社. As a result, 八幸通商株式会社 is scheduled to be excluded from the scope of consolidation.

Worth reading
58In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
90
Percentage of total shares issued (%)
Wording
Conditional
How definitive the wording is.

This transaction

Share Transfers
Counterparty渡辺化学工業株式会社
Disclosing companyMANAC Chemical Partners Co.,Ltd
八幸通商株式会社Voting rights ownership percentage

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.

TimelineThe spacing between the points is proportional to the actual number of days.31 days from 決議 / 締結 to 実行.White points represent dates designated as scheduled dates in the document.
Target company

開発品の合成研究(工業化検討)を含む受託生産及び化学品の国内販売及び輸出入

Location Chuo-ku, TokyoShare capital ¥20 millionDate of incorporation 1983 年4月 15 日
Net Sales1,306 百万円(2023 年3月期)
Operating profit△26 百万円(2023 年3月期)
Net income for the current fiscal year△13 百万円(2023 年3月期)
Net assets213 百万円(2023 年3月期)
Consideration and expenses
Acquisition price株式譲渡契約書における相手先の意向を踏まえ開示を控える
Impact on Business Performance

本株式譲渡が当社の2024年3月期連結業績に与える影響は現在精査中であり、開示すべき内容が判明した時点ですみやかに公表いたします。

Procedures and assumptions
Valuation methodology公正なプロセスを経た相手先との交渉、及び該当会社の直近の業績や経営状態、並びに今後の業績見通し等を総合的に勘案
This transaction
ItemDetails
Transaction nameShare Transfers
Counterparty name渡辺化学工業株式会社
Name of the Subject Company八幸通商株式会社
Business Description of the Subject Company開発品の合成研究(工業化検討)を含む受託生産及び化学品の国内販売及び輸出入
Location of the Subject CompanyChuo-ku, Tokyo
Capital Stock of the Subject Company¥20 million
Date of Establishment of the Subject Company1983 年4月 15 日
Net Sales of the Subject Company1,306 百万円(2023 年3月期)
Operating Profit of the Subject Company△26 百万円(2023 年3月期)
Net Income of the Subject Company△13 百万円(2023 年3月期)
Net Assets of the Subject Company213 百万円(2023 年3月期)
Acquisition price株式譲渡契約書における相手先の意向を踏まえ開示を控える
Voting rights ownership percentageBefore 90.0% → after 0.0%
Impact on Business Performance本株式譲渡が当社の2024年3月期連結業績に与える影響は現在精査中であり、開示すべき内容が判明した時点ですみやかに公表いたします。
Date of board resolution2024 年2月 29 日
Contract Date2024 年2月 29 日
Execution Date / Effective Date2024 年3月 31 日(予定)
Valuation methodology公正なプロセスを経た相手先との交渉、及び該当会社の直近の業績や経営状態、並びに今後の業績見通し等を総合的に勘案
Items this document does not state (14)
Expenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Independent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

八幸通商が保有していた中国製造拠点の持分を2018年に譲渡して以降、保有設備の容量制約等により、当社グループの他事業とのシナジーが見込みにくい状況となっていたため。継続的な事業ポートフォリオの見直しの一環として、八幸通商の在り方を検討した結果、本株式譲渡を決議した。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Change in Consolidated Subsidiary (Share Transfer) | MANAC Chemical Partners Co.,Ltd (4360) timely disclosure | Komori